<?xml version="1.0" encoding="UTF-8"?>
<ref id="cam41388-bib-0014">
 <label>14</label>
 <mixed-citation publication-type="journal" id="cam41388-cit-0014">
  <string-name>
   <surname>Bondarenko</surname>, 
   <given-names>I.</given-names>
  </string-name>, 
  <string-name>
   <given-names>O. A.</given-names>
   <surname>Gladkov</surname>
  </string-name>, 
  <string-name>
   <given-names>R.</given-names>
   <surname>Elsaesser</surname>
  </string-name>, 
  <string-name>
   <given-names>A.</given-names>
   <surname>Buchner</surname>
  </string-name>, and 
  <string-name>
   <given-names>P.</given-names>
   <surname>Bias</surname>
  </string-name>. 
  <year>2013</year>
  <article-title>Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active‚Äêcontrol phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy</article-title>. 
  <source>BMC Cancer</source>
  <volume>13</volume>:
  <fpage>386</fpage>.
  <pub-id pub-id-type="pmid">23945072</pub-id>
 </mixed-citation>
</ref>
